Article

Gastrointestinal Radiology

, Volume 14, Issue 1, pp 55-58

Liver function tests in patients with computed tomography demonstrated hepatic metastases

  • Mark D. OttmarAffiliated withDepartment of Diagnostic Imaging and Interventional Radiology, Providence Hospital
  • , Roger L. GondaJr.Affiliated withDepartment of Radiology, University of Rochester School of Medicine and Dentistry
  • , Kurt J. LeithauserAffiliated withDepartment of Diagnostic Imaging and Interventional Radiology, Providence Hospital
  • , Oscar H. GutierrezAffiliated withDepartment of Radiology, University of Rochester School of Medicine and Dentistry

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

One hundred patients with computed tomographic (CT) evidence of liver metastases (and confirmation by biopsy or progression of disease) had serum levels of alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase measured within two weeks of scanning. All three enzymes were within the normal range in 33% of patients. Even with advanced involvement (defined as three or more metastatic lesions over 3 cm in diameter), 20% of patients had normal levels of all three liver enzymes. Although liver function tests (LFTs) (enzyme levels) are inexpensive and simple to perform, they failed to detect a significant number of patients with liver metastases.

Key words

Liver, computed tomography Liver, metastases